182 related articles for article (PubMed ID: 3532334)
1. Alpha interferon treatment of low-grade B-cell non-Hodgkin's lymphomas, cutaneous T-cell lymphomas, and chronic lymphocytic leukemia.
Foon KA; Roth MS; Bunn PA
Semin Oncol; 1986 Sep; 13(3 Suppl 2):35-42. PubMed ID: 3532334
[TBL] [Abstract][Full Text] [Related]
2. Alpha-interferon treatment of cutaneous T cell lymphoma and chronic lymphocytic leukemia.
Foon KA; Bunn PA
Semin Oncol; 1986 Dec; 13(4 Suppl 5):35-9. PubMed ID: 3541217
[TBL] [Abstract][Full Text] [Related]
3. Alpha interferon in the treatment of hematologic malignancies.
Roth MS; Foon KA
Am J Med; 1986 Nov; 81(5):871-82. PubMed ID: 3535496
[TBL] [Abstract][Full Text] [Related]
4. Interferon therapy of non-Hodgkin's lymphoma.
Foon KA; Roth MS; Bunn PA
Cancer; 1987 Feb; 59(3 Suppl):601-4. PubMed ID: 3492259
[TBL] [Abstract][Full Text] [Related]
5. [Alpha interferon in therapy of non-Hodgkin's lymphoma].
Freund M; Hanauske AR
Onkologie; 1990 Dec; 13(6):424-8. PubMed ID: 2092278
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study.
O'Connell MJ; Colgan JP; Oken MM; Ritts RE; Kay NE; Itri LM
J Clin Oncol; 1986 Feb; 4(2):128-36. PubMed ID: 3511183
[TBL] [Abstract][Full Text] [Related]
7. The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas.
Bunn PA; Ihde DC; Foon KA
Cancer; 1986 Apr; 57(8 Suppl):1689-95. PubMed ID: 3485012
[TBL] [Abstract][Full Text] [Related]
8. Recombinant interferon alfa-2a, an active agent in advanced cutaneous T-cell lymphomas.
Bunn PA; Ihde DC; Foon KA
Int J Cancer Suppl; 1987; 1():9-13. PubMed ID: 3305390
[TBL] [Abstract][Full Text] [Related]
9. [Various aspects and results of therapy with interferon].
Niederle N
Arzneimittelforschung; 1988 Mar; 38(3A):449-53. PubMed ID: 2456071
[TBL] [Abstract][Full Text] [Related]
10. Biotherapy with interferon--1988.
Figlin RA
Semin Oncol; 1988 Dec; 15(6 Suppl 6):3-9. PubMed ID: 2462749
[TBL] [Abstract][Full Text] [Related]
11. Complete remission following recombinant interferon alpha-2a in a patient with diffuse large B cell cutaneous lymphoma.
Tourani JM; Leaute JB; Lessana-Leibowitch M; Andrieu JM
Nouv Rev Fr Hematol (1978); 1989; 31(4):315-6. PubMed ID: 2691984
[TBL] [Abstract][Full Text] [Related]
12. Current and future uses of recombinant interferon alpha in the treatment of low-grade non-Hodgkin's lymphoma.
Steis RG; Foon KA; Longo DL
Cancer; 1987 Feb; 59(3 Suppl):658-63. PubMed ID: 10822466
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of leukemias and lymphomas with interferons: III. Trial treatment of meningeal localizations of acute leukemia and non-Hodgkin's lymphomas with beta interferon administered by the intrathecal route].
Misset JL; Mathé G; Gastiaburu J; Goutner A; Dorval TI; Gouveia J; Hayat M; Jasmin C; Schwarzenberg L; Machover D; Ribaud P; de Vassal F; Horoszewicz JP
Biomed Pharmacother; 1982; 36(3):167-70. PubMed ID: 6758874
[TBL] [Abstract][Full Text] [Related]
14. Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas.
Bunn PA; Foon KA; Ihde DC; Longo DL; Eddy J; Winkler CF; Veach SR; Zeffren J; Sherwin S; Oldham R
Ann Intern Med; 1984 Oct; 101(4):484-7. PubMed ID: 6332565
[TBL] [Abstract][Full Text] [Related]
15. Phase I-II study of recombinant alpha-2 interferon against advanced leukemia and lymphoma in children.
Ochs J; Abromowitch M; Rudnick S; Murphy SB
J Clin Oncol; 1986 Jun; 4(6):883-7. PubMed ID: 3458876
[TBL] [Abstract][Full Text] [Related]
16. Chronic lymphoid leukemias: recent advances in biology and therapy.
Foon KA
Stem Cells; 1995 Jan; 13(1):1-21. PubMed ID: 7719244
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic options in advanced cutaneous T cell lymphomas: a role for interferon alfa-2a (Roferon-A).
Bunn PA; Foon KA
Semin Oncol; 1985 Dec; 12(4 Suppl 5):18-24. PubMed ID: 3878594
[TBL] [Abstract][Full Text] [Related]
18. The role of interferon in the therapy of malignant lymphoma.
McLaughlin P
Biomed Pharmacother; 1996; 50(3-4):140-8. PubMed ID: 8881370
[TBL] [Abstract][Full Text] [Related]
19. Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma.
Kuzel TM; Gilyon K; Springer E; Variakojis D; Kaul K; Bunn PA; Evans L; Roenigk HH; Rosen ST
J Natl Cancer Inst; 1990 Feb; 82(3):203-7. PubMed ID: 2296050
[TBL] [Abstract][Full Text] [Related]
20. Clinical trials of alpha-interferon in the treatment of non-Hodgkin's lymphoma.
Gaynor ER; Fisher RI
Semin Oncol; 1991 Oct; 18(5 Suppl 7):12-7. PubMed ID: 1948124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
